Bausch+Lomb News

1. This RSS feed URL is deprecated

   This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

2. Valeant to change name to Bausch Health Cos. in July - Rochester Democrat and Chronicle

   Rochester Democrat and Chronicle

   Valeant to change name to Bausch Health Cos. in July Rochester Democrat and Chronicle This was the first time since 2015 that the company delivered overall organic revenue growth, based on success in the Branded Rx and Bausch and Lomb/International segments, he continued, which showed 8 percent and 2 percent organic revenue growth ... Valeant, Distancing Itself From Its Past, Will Change Its Name to Bausch HealthNew York Times Valeant Pharma reports quarterly loss, to change name to Bausch...CNBC Valeant Pharmaceuticals, which owns Bausch + Lomb owners, changes nameRochesterFirst MarketWatch -Investor's Business Daily -PharmaLive (press release) -Benzinga all 235 news articles »

3. Bausch + Lomb Launches LUMIFY, The First And Only OTC ... - PR Newswire (press release)

   GuruFocus.com

   Bausch + Lomb Launches LUMIFY, The First And Only OTC... PR Newswire (press release) LAVAL, Quebec, May 7, 2018 /PRNewswire/ -- Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose ... CNW | Bausch + Lomb Launches LUMIFY, The First And Only OTC...Canada NewsWire (press release) all 2 news articles »

4. Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for ... - PR Newswire (press release)

   Nasdaq

   Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for... PR Newswire (press release) Lenses Can Be Worn for Up to Six Nights and Seven Days Continuously. LAVAL, Quebec, May 2, 2018 /PRNewswire/ -- Bausch + Lomb, a leading global eye ... Bausch + Lomb ULTRA Contact Lenses Get FDA Approval For...Nasdaq Valeant Pharma's (VRX) Bausch + Lomb Announces FDA Approval...StreetInsider.com ULTRA Contact Lenses Granted FDA Approval for Extended Wear...MD Magazine Healio all 3 news articles »

5. Bausch + Lomb initiates OVD clinical trial - Healio

   Healio

   Bausch + Lomb initiates OVD clinical trial Healio “OVDs play a critical role in ophthalmic surgery, and selection is highly individualized based on clinical surgical requirements and the surgeon's preferences,” Chuck Hess, vice president and general manager of U.S. Surgical at Bausch + Lomb, said in ...

6. No Jane Doe: Attorney Can't Hide Identity in Suit Against Bausch & Lomb, Valeant Pharmaceuticals - Law.com

   Law.com

   No Jane Doe: Attorney Can't Hide Identity in Suit Against Bausch & Lomb, Valeant Pharmaceuticals Law.com Her ruling came in a products liability lawsuit against Irvine, California-based eye health care supplier Bausch & Lomb and Canadian multinational specialty pharmaceutical company Valeant Pharmaceuticals, which has U.S. headquarters in Bridgewater, ...

7. Bausch & Lomb Suit Must ID Law Firm Partner Plaintiff - Bloomberg Big Law Business

   Bloomberg Big Law Business

   Bausch & Lomb Suit Must ID Law Firm Partner Plaintiff Bloomberg Big Law Business A law firm partner and her husband can't use pseudonyms in a suit against Bausch & Lomb Inc. related to the lawyer's loss of sight, a federal court in Connecticut said. Concern about economic harm isn't a sufficient reason to conceal their identities ...

8. Bausch + Lomb Will Present Scientific And Clinical Research During ... - PR Newswire (press release)

   GuruFocus.com

   Bausch + Lomb Will Present Scientific And Clinical Research During... PR Newswire (press release) LAVAL, Quebec, April 27, 2018 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company, and wholly owned subsidiary of Valeant ... Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And...Stockhouse all 1 news articles »

9. Bausch + Lomb to launch scleral contact lens case - Healio

   Healio

   Bausch + Lomb to launch scleral contact lens case Healio “The introduction of our new Boston scleral lens case addresses an unmet need of eye care professionals and patients,” John Ferris, general manager, U.S. Vision Care, Bausch + Lomb, said in the release. “Our latest innovation is specifically designed ...

10. Global Intraocular Lens (IOLs) Market 2018 Evaluation- ALCON, Bausch + Lomb, AMO (Abbott), CARL Zeiss and HOYA - Exclusive Reportage

    Positive Columnist

    Global Intraocular Lens (IOLs) Market 2018 Evaluation- ALCON, Bausch + Lomb, AMO (Abbott), CARL Zeiss and HOYA Exclusive Reportage Global Intraocular Lens (IOLs) Market 2018, describes an in-depth evaluation and professional study on the present state of the Intraocular Lens (IOLs) market across the globe. This provides a basic overview of Intraocular Lens (IOLs) market including ... Global Intraocular Lens (IOL) Market Competitive Insights 2018: HOYA, CARL Zeiss, Ophtec and Bausch + LombClean Technology Intraocular Lens Market Research Report 2018: In-Depth Analysis, Top Key player Johnson & Johnson, Bausch...Technical Progress Global Rigid Intraocular Lens Market 2018 – Bausch + Lomb, Biotech Visioncare, SolekoFirst News 24 Positive Columnist -Investor Opinion all 42 news articles »

11. Bausch + Lomb launches Lumify for ocular redness - Healio

    Healio

    Bausch + Lomb launches Lumify for ocular redness Healio Lumify (brimonidine tartrate ophthalmic solution 0.025%) showed a strong safety and efficacy profile in clinical trials, with low risk for rebound redness and 95% symptom improvement seen at 1 minute and lasting up to 8 hours, according to a Bausch + ...